Dokkyo Medical University’s publication on International Journal of Molecular Sciences.
International Journal of Molecular Sciencesにて弊社クライアント様による論文発表がございましたのでご紹介させて頂きます。
Title: “The SGLT2 Inhibitor Canagliflozin Prevents Carcinogenesis in a Mouse Model of Diabetes and Non-Alcoholic Steatohepatitis-Related Hepatocarcinogenesis: Association with SGLT2 Expression in Hepatocellular Carcinoma”